Import Apixaban Tablet — Buy in wholesale FOB from Supplier in India

Apixaban tablet is a direct oral anticoagulant (DOAC) and Factor Xa inhibitor supplied as film-coated oral tablets in standard dosage strengths, with this particular offering from XYZ test based in Cuttack, Odisha. The active pharmaceutical ingredient functions to prevent thrombus formation by selectively inhibiting Factor Xa, a critical enzyme in the coagulation cascade, with the formulation containing glucose and fructose as excipient components. This finished pharmaceutical product requires cold-chain storage throughout distribution and full compliance with pharmaceutical import and export regulations including GDP and GMP certification for entry into regulated markets.

The film-coated tablet format provides gastric protection and improved patient compliance compared with uncoated alternatives, with standard pharmaceutical-grade coatings typically comprising hypromellose, titanium dioxide, and glycerol. The glucose and fructose content in the excipient profile is significant for buyers serving diabetic populations or those with specific dietary restrictions, requiring careful review of the full Certificate of Analysis. Factor Xa inhibitors as a class have displaced warfarin in many clinical guidelines due to their predictable pharmacokinetics and reduced monitoring burden, though regional formularies vary in their reimbursement and procurement preferences. The standard dosage strengths align with established treatment protocols for stroke prevention in non-valvular atrial fibrillation and for DVT/PE treatment and prophylaxis.

International buyers of this product include hospital procurement consortia, government pharmaceutical supply programmes, wholesale distributors, and specialty pharmaceutical importers serving regulated markets. Primary applications span chronic anticoagulation for atrial fibrillation patients, acute and extended treatment of venous thromboembolism, and post-surgical prophylaxis following hip or knee replacement. Trade terms for this controlled pharmaceutical product typically require confirmed GMP certification, valid export licences from the Drugs Controller General of India, and destination-country import authorisation. Buyers should confirm with XYZ test directly regarding specific batch documentation, stability data, and whether the manufacturing site holds current EU GMP, US FDA, or WHO-PQ inspection status, as these accreditations determine market access.

XYZ test

India🚢 Voyage

5(64)

XYZ test operates from an address at XYZ- Civil Lines in Cuttack, Odisha, India, with its supplier tier classified as organic and trust tier recorded as voyage. The supplier maintains a response rate of 0.00 percent with an average response time of zero hours, indicating that direct communication channels may be limited or that the profile has not yet established active engagement patterns. No additional facility information, manufacturing capacity, or regulatory accreditation specifics are present in the available profile data for this entity.

The listing presents Apixaban tablet as a finished pharmaceutical product for international trade, with emphasis on cold-chain logistics and regulated-market compliance. What the profile does not state includes: years in operation, total employee count, annual production capacity, specific GMP certifications held, export licence numbers, client references, or whether manufacturing occurs at the Cuttack address or at a separate facility under third-party arrangement. Buyers should treat this as an early-stage engagement and conduct standard pharmaceutical supplier due diligence including facility audit, batch record review, and regulatory database verification before committing to procurement.